I
Instituto Brasil de Pesquisa Clinica | Rio de Janeiro, Brazil
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BI 690517
Empagliflozin
Semaglutide
Vicadrostat
BI 456906
Survodutide
Guselkumab
Golimumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...
Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide
This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People ca...
Enrolling
Heart Failure
Drug: Placebo matching vicadrostat
Drug: Empagliflozin
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left...
Enrolling
Heart Failure
Drug: vicadrostat
Drug: Empagliflozin
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems